EUVIMEDEUVIMED entdecken
Crossref

Coenzyme Q10 Administration Attenuates Diabetic Cardiomyopathy in Wistar Rats

TO Olaleye, BO Adele, AO Ige, EO Adewoye

Journal of Medicine and Biomedical Research · 2025 · 24 (2) · 85-95

DOI: 10.4314/jmbr.v24i2.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicine and Biomedical Research, 2025. Verfasst von TO Olaleye und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The activity of adenosine monophosphate activated protein Kinase (AMPK) is essential in maintaining overall cardiac health and preventing cardiomyopathy. This study investigated cardiac oxidative stress, inflammation and AMPK activity in Wistar rats with diabetic cardiomyopathy that were treated with Coenzyme Q10 (CoQ10), a substance known for its potent antioxidant and anti-inflammatory properties.

Methods

Forty-eight female Wistar rats (100-150 g) were divided into six groups (n=8). Diabetic cardiomyopathy (DCM) was induced using 10% fructose in drinking water and streptozotocin (STZ) (40 mg/kg i.p.). Animals were thereafter grouped and treated as follows for 2 weeks; groups I (control), II (vehicle control) and III were non-diabetic, and received distilled water (2mL/kg/day), (Olive oil, 2ml/kg/day), and CoQ10 (100mg/kg/day). DCM was induced in groups IV-VI and thereafter animals were treated with distilled water, CoQ10 and metformin (250mg/kg/day), respectively. Blood sample were obtained and analysed for fasting glucose, insulin and B-type natriuretic peptide (BNP). cardiac samples were assayed for AMPK, GLUT 4, and interleukin 6. Insulin resistance was estimated mathematically while cardiac histology was evaluated using standard methods.

Results

Untreated experimental DCM resulted in hyperglycemia, hyper-insulinaemia, insulin resistance, elevated BNP, reduced AMPK and GLUT 4 as well ventricular hypertrophy. Treatment with CoQ10 positively affected AMPK activity, exerted ameliorative effects, but did not completely reverse the cardiac structural aberrations caused by DCM.

Conclusion

Coenzyme Q10 attenuates experimental diabetic cardiomyopathy through mechanisms associated with regulating cardiac energy metabolism and reducing inflammation.

Zitieren

APA

Olaleye, T., Adele, B., Ige, A., & Adewoye, E. (2025). Coenzyme Q10 Administration Attenuates Diabetic Cardiomyopathy in Wistar Rats. Journal of Medicine and Biomedical Research, 24(2), 85-95. https://doi.org/10.4314/jmbr.v24i2.11

Vancouver

Olaleye T, Adele B, Ige A, Adewoye E. Coenzyme Q10 Administration Attenuates Diabetic Cardiomyopathy in Wistar Rats. Journal of Medicine and Biomedical Research. 2025;24(2):85-95. doi:10.4314/jmbr.v24i2.11

BibTeX
@article{Olaleye2025,
  author = {Olaleye, TO and Adele, BO and Ige, AO and Adewoye, EO},
  title = {Coenzyme Q10 Administration Attenuates Diabetic Cardiomyopathy in Wistar Rats},
  journal = {Journal of Medicine and Biomedical Research},
  year = {2025},
  volume = {24},
  number = {2},
  pages = {85--95},
  doi = {10.4314/jmbr.v24i2.11}
}
Kostenlos starten →